IL6 and neoplasm: Meanwhile, in colorectal cancer, IL1R2 is involved in activating IL6, VEGFA, and MEK/ERK, promoting cell proliferation and metastasis, promoting tumor angiogenesis, and enhancing tumor drug resistance [80].